T0	Outcomes 238 257	efficacy and safety
T1	Outcomes 934 958	endpoint was AM pre-dose
T2	Outcomes 990 1085	included other measures of lung function, rescue albuterol use, health status and exacerbations
T3	Outcomes 1122 1260	significantly improved lung function indices including AM pre-dose FEV(1), 2 h post-dose FEV(1), AM pre-dose FVC, 2 h post-dose FVC and AM
T4	Outcomes 1348 1382	alone in reducing rescue albuterol
T5	Outcomes 1447 1502	treatment groups in health status or COPD exacerbations
T6	Outcomes 1508 1528	incidence of adverse
T7	Outcomes 1635 1662	significantly improves lung
T8	Outcomes 1680 1699	increasing the risk